Environmental Impact Acquisition Corp.
ENVIU
NASDAQ Global Select8.75
USD
+0.18
- -
CIK
0001822691
ISIN
US29408N2053
CUSIP
29408N205
Return %
Stock
S&P500
1Y
- -
26.53
3Y
- -
76.60
5Y
-17.92
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 535 Madison Avenue New York City NY United States of America 10022
- IPO Date
- Jan 14, 2021
- CIK
- 0001822691
- Website
- canaccordgenuity.com
- Similar Companies
- Business
- Environmental Impact Acquisition Corp is a special purpose acquisition company (SPAC) incorporated in 2020 and headquartered in New York, New York. The company focuses on effecting mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or other similar business combinations, primarily targeting sectors such as smart building technologies, smart grid and smart city solutions, energy efficiency and decarbonization, renewable energy and distributed generation, electric vehicles and mobility, agriculture and food technology, recycling and remediation, and water and bioresources. As of early 2022, Environmental Impact Acquisition Corp completed a reverse merger with GreenLight Biosciences, a biotechnology company specializing in RNA technology for human health and agriculture, resulting in the company changing its name to GreenLight Biosciences Holdings and trading under new symbols. The merger and associated PIPE financing rounds have positioned the combined entity to leverage RNA product pipelines aimed at healthcare and agricultural markets globally. Environmental Impact Acquisition Corp itself had no significant operations before the merger and focused on identifying and consummating strategic business combinations aligned with environmental and sustainable technologies. The company’s core activity transitioned towards advancing GreenLight Biosciences’ RNA platform and expanding its biotechnological applications post-transaction.
Get Rich And Save The Earth With ESG SPAC Climate II